Showing posts with label Cannabis Cures Cancer cannabis marijuana. Show all posts
Showing posts with label Cannabis Cures Cancer cannabis marijuana. Show all posts

Marijuana-Tumor Research hidden by U.S. Government


A Spanish medical team’s study released in Madrid in February 2000 has shown that tetrahydrocannabinol (THC), the active chemical in marijuana, destroys tumors in lab rats. These findings, however, are not news to the U.S. government. A study in Virginia in 1974 yielded similar results but was suppressed by the DEA, and in 1983 the Reagan/Bush administration tried to persuade U.S. universities and researchers to destroy all cannabis research work done between 1966 and 1976, including compendiums in libraries.
The research was conducted by a medical team led by Dr. Manuel Guzman of Complutence University in Madrid. In the study, brains of 45 lab rats were injected with a cancer cell, which produced tumors. On the twelfth day of the experiment, 15 of the rats were injected with THC and 15 with Win-55, 212-2, a synthetic compound similar to THC. The untreated rats died 12-18 days after the development of the tumors. THC treated rats lived significantly longer than the control group. Although three were unaffected by the THC, nine lived 19-35 days, while tumors were completely eradicated in three others. The rats treated with Win-55,212-2 showed similar results.
In an e-mail interview for this story, the Madrid researcher said he had heard of the Virginia study, but had never been able to locate literature on it. “I am aware of the existence of that research. In fact I have attempted many times to obtain the journal article on the original investigation by theses people, but it has proven impossible,” Guzman said. His response wasn’t surprising, considering that in 1983 the Reagan/Bush administration tried to persuade American universities and researchers to destroy all 1966/76 cannabis research work, including compendiums in libraries, reports Jack Herer. “We know that large amounts of information have since disappeared,” he says.
Guzman provided the title of the work-”Antineoplastic Activity of Cannabinoids,” an article in a 1975 Journal of the National Cancer Institute-and author Raymond Cushing obtained a copy at the UC Medical School Library in Davis, California, and faxed it to Madrid. The 1975 article does not mention breast cancer tumors, which were featured in the only newspaper story ever to appear about the 1974 study in the local section of the Washington Post on August 18, 1974. The headline read, “Cancer Curb Is Studied,” and was followed in part by, “The active chemical agent in marijuana curbs the growth of three kinds of cancer in mice and may also suppress the immunity reaction that causes rejection of organ transplants, a Medical College of Virginia team has discovered. The researchers found that THC slowed the growth of lung cancers, breast cancers, and a virus-induced leukemia in laboratory mice, and prolonged their lives by as much as 36 percent.”
Drug Enforcement Agency officials shut down the Virginia study and all further cannabis research, according to Jack Herer, who reports on these events in his book, The Emperor Wears No Clothes. In 1976, President Gerald Ford put an end to all public cannabis research and granted exclusive research rights to major pharmaceutical companies. These companies set out-unsuccessfully-to develop synthetic forms of THC that would deliver all the medical benefits without the “high.”

Update by Raymond Cushing

Cannabis And Cognition Claim


Washington, DC: Research published this week in the journal Neurology speculating that marijuana's effects on the cerebrovascular system may bring about residual cognitive deficits in longtime users is not supported by the majority of available clinical evidence.
Numerous prior reviews of marijuana's potential impact on neurocognitive performance include:

2003 meta-analysis published in the Journal of the International Neuropsychological Society that "failed to reveal a substantial, systematic effect of long-term, regular cannabis consumption on the neurocognitive functioning of users who were not acutely intoxicated;"

2002 clinical trial published in the Canadian Medical Association Journal that determined, "Marijuana does not have a long-term negative impact on global intelligence;"

2001 study published in the journal Archives of General Psychiatry that found that long-term cannabis smokers who abstained from the drug for one week "showed virtually no significant differences from control subjects (those who had smoked marijuana less than 50 times in their lives) on a battery of 10 neuropsychological tests." Researchers added, "Former heavy users, who had consumed little or no cannabis in the three months before testing, [also] showed no significant differences from control subjects on any of these tests on any of the testing days;"

1999 clinical trial published in the American Journal of Epidemiology that found "no significant differences in cognitive decline between heavy users, light users, and nonusers of cannabis" over a 15-year period.

More recently, a study published last fall in the journal Psychological Medicineexamining the potential long-term residual effects of cannabis on cognition in monozygotic male twins reported "an absence of marked long-term residual effects of marijuana use on cognitive abilities."
In addition, a scientific review published earlier this month in the journalCurrent Opinion in Pharmacology concluded, "There is little evidence ... that long-term cannabis uses causes permanent cognitive impairment. ... Overall, by comparison with other drugs used mainly for 'recreational' purposes, cannabis could be rated a relatively safe drug."
For more information, please contact, Shimon , using the box below,or Email knowyourcannabis@gmail.com  or Allen St. Pierre or Paul Armentano of National Organization for the Reform of Marijuana Law